Haru Morita
Gründer bei MODALIS THERAPEUTICS CORPORATION
Vermögen: 3 Mio $ am 30.04.2024
Aktive Positionen von Haru Morita
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MODALIS THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | 01.01.2016 | - |
Vorstandsvorsitzender | 01.01.2016 | - | |
Gründer | 01.01.2016 | - | |
Präsident | 01.01.2016 | - | |
Modalis Therapeutics, Inc. | Vorstandsvorsitzender | 01.04.2016 | - |
Karriereverlauf von Haru Morita
Ehemalige bekannte Positionen von Haru Morita
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Vorstandsvorsitzender | 01.03.2006 | - |
Vorsitzender | 01.03.2006 | - | |
Gründer | 01.03.2006 | - | |
Präsident | 01.03.2006 | - | |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Corporate Officer/Principal | - | - |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Technik-/Wissenschafts-/F&E-Leiter | 15.07.2009 | - |
Corporate Officer/Principal | - | 15.07.2009 | |
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Corporate Officer/Principal | - | - |
Ausbildung von Haru Morita
School of Engineering, The University of Tokyo | Graduate Degree |
Statistik
International
Japan | 5 |
Vereinigte Staaten | 3 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Executive Officer | 3 |
Founder | 2 |
Sektoral
Health Technology | 4 |
Consumer Non-Durables | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MODALIS THERAPEUTICS CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
Y's Therapeutics, Inc.
Y's Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Y's Therapeutics, Inc. manufactures biopharmaceuticals. | Health Technology |
Kirin Brewery Co. Ltd.
Kirin Brewery Co. Ltd. Beverages: AlcoholicConsumer Non-Durables Kirin Brewery Co., Ltd. engages in the manufacture of alcoholic beverages. Its products include beer, sparkling liquor, chuhai, gin, and whiskey. The company was founded in 1901 and is headquartered in Tokyo, Japan. | Consumer Non-Durables |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
Booz Allen Hamilton International (U.K.) Ltd.
Booz Allen Hamilton International (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Booz Allen & Hamilton International provides management and technology consulting services. The company provides services to international corporations and governments around the world. It was founded in 1914 and is located in McLean, VA. | Commercial Services |
Modalis Therapeutics, Inc. |
- Börse
- Insiders
- Haru Morita
- Erfahrung